SREK1IP1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
endothelial cell	23 studies	23% ± 9%	Explore
natural killer cell	16 studies	19% ± 4%	Explore
fibroblast	11 studies	22% ± 7%	Explore
macrophage	10 studies	22% ± 7%	Explore
classical monocyte	8 studies	21% ± 7%	Explore
epithelial cell	8 studies	37% ± 18%	Explore
endothelial cell of lymphatic vessel	7 studies	21% ± 6%	Explore
CD16-positive, CD56-dim natural killer cell, human	7 studies	20% ± 3%	Explore
pericyte	7 studies	19% ± 4%	Explore
capillary endothelial cell	6 studies	18% ± 4%	Explore
smooth muscle cell	6 studies	20% ± 3%	Explore
basal cell	6 studies	32% ± 14%	Explore
ciliated cell	6 studies	34% ± 14%	Explore
plasmacytoid dendritic cell	6 studies	21% ± 5%	Explore
mature NK T cell	5 studies	17% ± 2%	Explore
monocyte	5 studies	19% ± 3%	Explore
endothelial cell of artery	5 studies	18% ± 2%	Explore
astrocyte	5 studies	29% ± 7%	Explore
pancreatic A cell	4 studies	34% ± 14%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	4 studies	19% ± 4%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	4 studies	20% ± 5%	Explore
non-classical monocyte	4 studies	23% ± 8%	Explore
B cell	4 studies	26% ± 3%	Explore
CD16-negative, CD56-bright natural killer cell, human	4 studies	20% ± 4%	Explore
myofibroblast cell	4 studies	17% ± 2%	Explore
connective tissue cell	4 studies	18% ± 4%	Explore
type I pneumocyte	4 studies	25% ± 9%	Explore
goblet cell	4 studies	22% ± 5%	Explore
CD8-positive, alpha-beta memory T cell	4 studies	19% ± 1%	Explore
gamma-delta T cell	4 studies	26% ± 16%	Explore
type B pancreatic cell	3 studies	37% ± 14%	Explore
naive B cell	3 studies	17% ± 2%	Explore
CD4-positive, alpha-beta T cell	3 studies	26% ± 3%	Explore
CD8-positive, alpha-beta T cell	3 studies	27% ± 4%	Explore
conventional dendritic cell	3 studies	32% ± 8%	Explore
effector memory CD8-positive, alpha-beta T cell	3 studies	23% ± 6%	Explore
hematopoietic precursor cell	3 studies	23% ± 9%	Explore
neuron	3 studies	29% ± 9%	Explore
myeloid cell	3 studies	26% ± 7%	Explore
retina horizontal cell	3 studies	32% ± 11%	Explore
retinal cone cell	3 studies	35% ± 9%	Explore
erythroblast	3 studies	28% ± 14%	Explore
endothelial cell of vascular tree	3 studies	19% ± 2%	Explore
GABAergic neuron	3 studies	35% ± 3%	Explore
glutamatergic neuron	3 studies	49% ± 4%	Explore
pancreatic ductal cell	3 studies	34% ± 11%	Explore
abnormal cell	3 studies	22% ± 3%	Explore
enteroendocrine cell	3 studies	26% ± 9%	Explore
intestinal crypt stem cell	3 studies	17% ± 2%	Explore
oligodendrocyte	3 studies	20% ± 3%	Explore
double negative thymocyte	3 studies	26% ± 13%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	6 studies	30% ± 11%	Explore
peripheral blood	5 studies	25% ± 6%	Explore
brain	5 studies	30% ± 10%	Explore
eye	4 studies	24% ± 8%	Explore
pancreas	3 studies	35% ± 13%	Explore
intestine	3 studies	22% ± 8%	Explore
liver	3 studies	30% ± 14%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
adrenal gland	100%	1372.76	258 / 258	100%	11.32	230 / 230
bladder	100%	1569.24	21 / 21	100%	10.85	504 / 504
breast	100%	1231.17	459 / 459	100%	12.01	1118 / 1118
esophagus	100%	1698.28	1445 / 1445	100%	21.39	183 / 183
liver	100%	662.50	226 / 226	100%	6.96	406 / 406
ovary	100%	1274.67	180 / 180	100%	10.38	430 / 430
pancreas	100%	784.77	328 / 328	100%	9.48	178 / 178
prostate	100%	1501.99	245 / 245	100%	10.15	502 / 502
thymus	100%	1205.66	653 / 653	100%	11.41	605 / 605
uterus	100%	1377.66	170 / 170	100%	12.38	459 / 459
brain	100%	1118.20	2641 / 2642	100%	10.63	705 / 705
lung	100%	1326.08	577 / 578	100%	12.77	1155 / 1155
intestine	100%	1409.25	966 / 966	100%	11.52	526 / 527
stomach	100%	1069.78	359 / 359	100%	13.74	285 / 286
kidney	100%	1110.02	89 / 89	99%	11.86	892 / 901
skin	100%	1781.10	1809 / 1809	93%	8.94	441 / 472
adipose	100%	1340.07	1204 / 1204	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	10.00	29 / 29
spleen	100%	1203.09	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	12.33	45 / 45
ureter	0%	0	0 / 0	100%	8.66	1 / 1
blood vessel	100%	1402.63	1334 / 1335	0%	0	0 / 0
muscle	99%	591.12	798 / 803	0%	0	0 / 0
heart	99%	659.15	855 / 861	0%	0	0 / 0
peripheral blood	79%	778.88	732 / 929	0%	0	0 / 0
eye	0%	0	0 / 0	61%	3.00	49 / 80
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0008380	Biological process	RNA splicing
GO_0006397	Biological process	mRNA processing
GO_0005515	Molecular function	protein binding
GO_0008270	Molecular function	zinc ion binding
GO_0003676	Molecular function	nucleic acid binding

IV. Literature review

[source]

Gene name	SREK1IP1
Protein name	Protein SREK1IP1 (SFRS12-interacting protein 1) (SREK1-interacting protein 1) (Splicing regulatory protein of 18 kDa) (p18SRP)
Synonyms	P18SRP SFRS12IP1
Description	FUNCTION: Possible splicing regulator involved in the control of cellular survival.
Accessions	Q8N9Q2 ENST00000513458.9

SREK1IP1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review